Exane Derivatives Royal Caribbean Cruises LTD Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Royal Caribbean Cruises LTD stock. As of the latest transaction made, Exane Derivatives holds 12 shares of RCL stock, worth $2,897. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 54
77.78%
Holding current value
$2,897
Previous $4,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RCL
# of Institutions
1,076Shares Held
205MCall Options Held
9.7MPut Options Held
11.5M-
Capital Research Global Investors Los Angeles, CA30.5MShares$7.37 Billion1.17% of portfolio
-
Capital International Investors Los Angeles, CA29.4MShares$7.11 Billion1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$6.28 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY16.7MShares$4.03 Billion0.06% of portfolio
-
Capital World Investors Los Angeles, CA13.7MShares$3.32 Billion0.39% of portfolio
About ROYAL CARIBBEAN CRUISES LTD
- Ticker RCL
- Exchange NYSE
- Sector Consumer Cyclical
- Industry Travel Services
- Shares Outstandng 255,059,008
- Market Cap $61.6B
- Description
- Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, Azamara, and Silversea Cruises brands, which comprise a range of itineraries that call on approximately 1,000 destinations. As of February 25, 2022, it operated 61 ships. The company was fo...